Source: Annual Congress 2011 - COPD exacerbation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Polosa, M. Malerba, A. Radaeli, J. Morjaria, R. Gullo, G. Di Maria (Catania, Brescia, Italy; Southampton, United Kingdom). Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients. Eur Respir J 2011; 38: Suppl. 55, 560

Member's Comments

No comment yet.

Related content which might interest you: Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 The importance of C-reactive protein in patients with acute exacerbation of severe COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Time course of systemic inflammatory markers during acute exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Systemic inflammatory profile of patients with acute coronary syndrome and concomitant COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003